Affectis has extensive expertise in drug discovery and behavioural pharmacology. Both platforms allow the company to extend and strengthen its pipeline.
Affectis' competencies have also been used by a number of large international pharmaceutical companies (e.g. Novartis, Organon, and Mitsubishi Pharma among others) to validate gene targets and assess the efficacy of drug candidates.
Copyright © 2010 Affectis Pharmaceuticals AG. All Rights Reserved.